BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 29950410)

  • 1. CD8
    Zhang Y; Wu Y; Deng M; Xu D; Li X; Xu Z; Hu J; Zhang H; Liu K; Zhao Y; Gao F; Bi S; Gao GF; Zhao J; Liu WJ; Meng S
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
    Liu Q; Zheng Y; Yu Y; Tan Q; Huang X
    Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
    Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals.
    Khakoo SI; Ling R; Scott I; Dodi AI; Harrison TJ; Dusheiko GM; Madrigal JA
    Gut; 2000 Jul; 47(1):137-43. PubMed ID: 10861276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy.
    Radecke K; Protzer U; Trippler M; Meyer Zum Büschenfelde KH; Gerken G
    J Med Virol; 2000 Dec; 62(4):479-86. PubMed ID: 11074477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8
    Karimzadeh H; Kiraithe MM; Oberhardt V; Salimi Alizei E; Bockmann J; Schulze Zur Wiesch J; Budeus B; Hoffmann D; Wedemeyer H; Cornberg M; Krawczyk A; Rashidi-Alavijeh J; Rodríguez-Frías F; Casillas R; Buti M; Smedile A; Alavian SM; Heinold A; Emmerich F; Panning M; Gostick E; Price DA; Timm J; Hofmann M; Raziorrouh B; Thimme R; Protzer U; Roggendorf M; Neumann-Haefelin C
    Gastroenterology; 2019 May; 156(6):1820-1833. PubMed ID: 30768983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure.
    Kefalakes H; Budeus B; Walker A; Jochum C; Hilgard G; Heinold A; Heinemann FM; Gerken G; Hoffmann D; Timm J
    Hepatology; 2015 Jul; 62(1):47-56. PubMed ID: 25720337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
    Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
    J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
    Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
    Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
    J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes.
    Hosono S; Tai PC; Wang W; Ambrose M; Hwang DG; Yuan TT; Peng BH; Yang CS; Lee CS; Shih C
    Virology; 1995 Sep; 212(1):151-62. PubMed ID: 7545853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B.
    Lin CL; Tsai SL; Lee TH; Chien RN; Liao SK; Liaw YF
    Gut; 2005 Jan; 54(1):152-61. PubMed ID: 15591521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.
    de Beijer MTA; Jansen DTSL; Dou Y; van Esch WJE; Mok JY; Maas MJP; Brasser G; de Man RA; Woltman AM; Buschow SI
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31852786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The L60V variation in hepatitis B virus core protein elicits new epitope-specific cytotoxic T lymphocytes and enhances viral replication.
    Zhang Y; Ren Y; Wu Y; Zhao B; Qiu L; Li X; Xu D; Liu J; Gao GF; Meng S
    J Virol; 2013 Jul; 87(14):8075-84. PubMed ID: 23678186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope.
    Liu HG; Chen WW; Fan ZP; Yang HY; Shi M; Zhang Z; Luan SS; Zhang H; Lu P; Tien P; Wang FS
    Clin Immunol; 2007 Dec; 125(3):337-45. PubMed ID: 17900990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes.
    Sun L; Zhang Y; Zhao B; Deng M; Liu J; Li X; Hou J; Gui M; Zhang S; Li X; Gao GF; Meng S
    Protein Cell; 2014 Apr; 5(4):317-27. PubMed ID: 24659387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice.
    Zhang Y; Li S; Shan M; Pan X; Zhuang K; He L; Gould K; Tien P
    Immunology; 2007 May; 121(1):105-12. PubMed ID: 17244158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
    Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
    BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA.
    Sendi H; Mehrab-Mohseni M; Shahraz S; Norder H; Alavian SM; Noorinayer B; Zali MR; Pumpens P; Bonkovsky HL; Magnius LO
    J Clin Virol; 2009 Nov; 46(3):259-64. PubMed ID: 19748824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.